[go: up one dir, main page]

MX9703249A - Composiciones orales de liberacion extendida de cisaprida. - Google Patents

Composiciones orales de liberacion extendida de cisaprida.

Info

Publication number
MX9703249A
MX9703249A MX9703249A MX9703249A MX9703249A MX 9703249 A MX9703249 A MX 9703249A MX 9703249 A MX9703249 A MX 9703249A MX 9703249 A MX9703249 A MX 9703249A MX 9703249 A MX9703249 A MX 9703249A
Authority
MX
Mexico
Prior art keywords
cisapride
extended release
oral compositions
release oral
medicine
Prior art date
Application number
MX9703249A
Other languages
English (en)
Other versions
MXPA97003249A (es
Inventor
Eugene Marie Jozef Jans
Paul Marie Victor Gilis
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MX9703249A publication Critical patent/MX9703249A/es
Publication of MXPA97003249A publication Critical patent/MXPA97003249A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cereal-Derived Products (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invencion se refiere a formulaciones de liberacion extendida que constan de (L)-tartrato de cisaprida, en particular una formulacion oral, el uso de la misma como medicina, especialmente en el tratamiento de desordenes gastrocinéticos.
MXPA/A/1997/003249A 1994-11-02 1997-04-30 Composiciones orales de liberacion extendida de cisaprida MXPA97003249A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP94203184.0 1994-11-02
EP94203184 1994-11-02
PCT/EP1995/004198 WO1996014070A1 (en) 1994-11-02 1995-10-25 Cisapride extended release oral compositions

Publications (2)

Publication Number Publication Date
MX9703249A true MX9703249A (es) 1997-07-31
MXPA97003249A MXPA97003249A (es) 1997-12-01

Family

ID=

Also Published As

Publication number Publication date
BG63244B1 (bg) 2001-07-31
AU3844795A (en) 1996-05-31
AP9700969A0 (en) 1997-04-30
FI971856A7 (fi) 1997-04-30
EE9700105A (et) 1997-12-15
IL115843A0 (en) 1996-01-31
HUT77887A (hu) 1998-09-28
US6274599B1 (en) 2001-08-14
TR199501351A2 (tr) 1996-06-21
UA50721C2 (uk) 2002-11-15
CA2203663A1 (en) 1996-05-17
RU2143890C1 (ru) 2000-01-10
MY113092A (en) 2001-11-30
JPH09511760A (ja) 1997-11-25
ZA959221B (en) 1997-04-30
AU704284B2 (en) 1999-04-15
TW466114B (en) 2001-12-01
FI971856A0 (fi) 1997-04-30
WO1996014070A1 (en) 1996-05-17
PL181470B1 (pl) 2001-07-31
BR9509565A (pt) 1997-09-16
FI971856L (fi) 1997-04-30
KR100255521B1 (ko) 2000-05-01
HRP950539A2 (en) 1997-08-31
NZ295166A (en) 1999-03-29
SK54297A3 (en) 1997-10-08
NO971832D0 (no) 1997-04-21
BG101401A (bg) 1997-12-30
US6153623A (en) 2000-11-28
RO116042B1 (ro) 2000-10-30
AR001765A1 (es) 1997-12-10
PL319948A1 (en) 1997-09-01
CZ124497A3 (en) 1997-08-13
NO971832L (no) 1997-04-21
EE03510B1 (et) 2001-10-15
EP0789572A1 (en) 1997-08-20
JP3182423B2 (ja) 2001-07-03
OA10419A (en) 2001-12-06
NO312538B1 (no) 2002-05-27
CZ287844B6 (en) 2001-02-14
AP658A (en) 1998-08-17
CA2203663C (en) 2002-04-30

Similar Documents

Publication Publication Date Title
BRPI0414800A (pt) composições de higiene oral baseadas em morinda citrifolia e seus usos
ES2162319T3 (es) Uso del agente quelante clioquinol para la fabricacion de una composicion farmaceutica para el tratamiento de la enfermedad de alzheimer.
ATE432685T1 (de) Orale anti-karies zusammensetzung
AR022008A1 (es) Una composicion de liberacion controlada de galantamina, un proceso para la preparacion de la misma, y el uso de dicha composicion para la preparacion de un medicamento
HN2001000027A (es) Derivados de purina
ES2171746T3 (es) Empleo de epinastina para el tratamiento de dolores.
GT200100153A (es) Compuestos de 1,4-dihidropiridina como antagonistas de bradiquinina.
AR022252A1 (es) Composicion de administracion oral.
ES2144151T3 (es) Benzotiazepinas hipolipidemicas.
MY129263A (en) Vaccine composition
AR034025A1 (es) Composiciones y kits para el cuidado de la dentadura postiza
ES2191034T3 (es) Formulaciones de liberacion controlada para la liberacion de metoprolol durante 24 horas.
ES2081110T3 (es) Composicion cosmetica o farmaceutica, particularmente dermatologica, destinada a favorecer la pigmentacion de la piel o de los cabellos, que contiene un extracto de cyperus y su procedimiento de fabricacion.
SE0001899D0 (sv) New compounds
AR021643A1 (es) Combinacion de cerivastatina y fibratos.
MX9300407A (es) Derivados azabiciclicos usados en la fabricacion de medicamentos, composiciones que los contienen y procedimiento para su preparacion.
BRPI0602329A (pt) composição de cuidados orais, dispositivos e métodos de uso das mesmas
CA2424566A1 (en) Dental care compositions
ES2174199T3 (es) Utilizacion de un poliholosido para estimular las defensas inmunitarias.
TR199802573A2 (xx) Bir etken madde i�eren ��kelmi� silisler.
CA2203663A1 (en) Cisapride extended release oral compositions
AR243379A1 (es) Composiciones orales que proveen una absorcion eficaz de fluoruro por parte del esmalte dental.
ES2170143T3 (es) Composiciones que comprenden halofantrina en una forma especial.
HN1999000196A (es) Derivados de indol
MX9300558A (es) Nueva sulfonilurea, procedimiento para su preparacion y formulado farmaceutico que la contiene.